The screenshot below records a genuine controversy about the speed of public access to the FDA’s Pfizer-BioNTech vaccine records. It is dated November 2021. It does not describe the disclosure timetable that ultimately followed, and it should not be read as a current promise to keep all records unavailable for 55 years.

Where the decades-long estimate came from
Public Health and Medical Professionals for Transparency brought a Freedom of Information Act case seeking records connected with the vaccine’s approval. In a November 2021 joint status report, the FDA proposed processing and releasing hundreds of pages each month. Against the volume of records involved, that pace produced a timeline measured in decades.
The dispute concerned processing and redaction for public disclosure. Reviewing a medical-product application and reviewing each page for release under information-access law are different tasks. Explaining that distinction does not settle whether the proposed pace was reasonable; the court was asked to address precisely that problem.
The court ordered a faster schedule
On 6 January 2022, the federal court ordered the FDA to produce 55,000 pages per month, beginning on 1 March 2022, after an initial production due that January. Later orders adjusted the schedule. The plaintiff’s public court-document archive includes those orders, allowing readers to examine the chronology rather than rely on the old screenshot alone.
Transparency matters because researchers and the public should be able to scrutinise the evidence behind major health decisions. A delay in disclosure deserves examination. It does not, on its own, establish that a product is harmful, that data were fabricated or that every document is being concealed.
Read the date as carefully as the headline
When an old news image recirculates, the most useful questions are what was requested, what the agency proposed, what the judge ordered and what happened next. The original image is preserved here as part of that history. Its message needs the subsequent court orders to become an accurate account of the dispute.
References
- PHMPT v. FDA: November 15, 2021 joint status report
- PHMPT v. FDA: January 6, 2022 disclosure order
- PHMPT: court-document archive and subsequent scheduling orders